2026 · Poster Presentation · Jazz Pharmaceuticals · Methods/Pharmacoepi
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Publications
4
Total Publications
4
Poster Presentation
2026 · Poster Presentation · Jazz Pharmaceuticals · Methods/Pharmacoepi
Real-World Dose Trajectory Patterns and Impact on Polypharmacy Burden and New Antiseizure Medication (ASM) Prescriptions in Patients With Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS), or Tuberous Sclerosis Complex (TSC) Receiving Cannabidiol (CBD)
Read more →2026 · Poster Presentation · Jazz Pharmaceuticals · Methods/Pharmacoepi
Real-World Effectiveness of Cannabidiol on Antiseizure Medication Cycling, Polypharmacy, and Healthcare Resource Utilization: A US Claims Analysis.
Read more →2025 · Poster Presentation · Jazz Pharmaceuticals · Methods/Pharmacoepi
Effect of Cannabidiol on Antiseizure Medication Cycling, Polypharmacy, and Healthcare Resource Utilisation in Patients With Dravet Syndrome, Lennox-Gastaut Syndrome, or Tuberous Sclerosis Complex: Real-World Data from a US Claims Analysis
Read more →Latest News
Contact us
By submitting this form, you consent to your information used by Headwater Science for the purpose of contacting you to better understand your potential interest in Headwater Science and/or its services. For more information, see our privacy policy.
Pedestal Health projects leverage Headwater Science methods, technology and causal inference expertise where the analytical complexity is highest, comparative effectiveness studies that require dynamic treatment design, regulatory-grade external control work, methodological consultation on submission packages, and the kinds of bias-protection frameworks that consequential evidence increasingly requires.
Pedestal Health projects leverage Headwater Science methods, technology and causal inference expertise where the analytical complexity is highest, comparative effectiveness studies that require dynamic treatment design, regulatory-grade external control work, methodological consultation on submission packages, and the kinds of bias-protection frameworks that consequential evidence increasingly requires.